GL1X · GenesisL1 explorer

Research workbench

Crystal structure of SHP2 E76K gof mutant in complex with SHP099

Analyse Crystal structure of SHP2 E76K gof mutant in complex with SHP099 in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
6CRG
Type
protein
Length
939 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Tyrosine-protein phosphatase non-receptor type 11
EC
3.1.3.48
UniProt
Q06124
Ligands
5OD, SO4
Pockets
11 · best druggability 0.67

Structure

x-ray diffraction · 2 distinct chains · 31% helix, 26% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ATyrosine-protein phosphatase non-receptor type 11 (EC 3.1.3.48)protein47730% helix, 25% strandQ06124
BTyrosine-protein phosphatase non-receptor type 11 (EC 3.1.3.48)protein46231% helix, 28% strandQ06124

Ligands and binding sites

  • 5OD · 6-(4-azanyl-4-methyl-piperidin-1-yl)-3-[2,3-bis(chloranyl)phenyl]pyrazin-2-amine · ligand · 2 copies · chains A, B
  • SO4 · Sulfate ion · ion · 8 copies · chains A, B
  • GOL · Glycerol · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

11 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
17370.670.7563empty
24030.660.80385OD
33940.650.79355OD, SO4
41260.480.7921SO4
5770.350.7616SO4

Interfaces

1 interface between chains.

  • A–B · 188 Ų buried · 3 hydrogen bonds · protein-protein

Compared structures

  • 6CRG · Crystal Structure of Shp2 E76K GOF Mutant in complex with SHP099 · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.